Personal and treatment-related predictors of abstinence self-efficacy.

Personal and treatment-related predictors of abstinence self-efficacy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Personal and treatment-related predictors of abstinence self-efficacy. Abstract Text:

Mark Ilgen,John McKellar,Rudolf Moos,

OBJECTIVE: To understand better the relationship between substance-use disorder treatment and abstinence self-efficacy, more information is needed about what factors predict greater abstinence self-efficacy. METHOD: Participants (n = 2,350) from 88 community residential facilities were assessed at treatment entry and 1-year follow-up. Treatment providers reported on patients' engagement in specific components of treatment. After examining univariate associations with self-efficacy, a multiple regression analysis was used to test a model of patient- and treatment-related predictors of self-efficacy 1 year after treatment. RESULTS: More years of education, lower baseline substance- related problems, and higher baseline confidence in abstinence were associated with higher posttreatment self-efficacy. After controlling for these patient factors, patients who were more engaged in skills-training activities and who inspired providers' confidence in their ability to remain abstinent had higher 1-year self-efficacy. CONCLUSIONS: The development of higher levels of posttreatment abstinence self-efficacy is driven not only by what a patient brings to treatment but by the activities a patient engages in during treatment. Because of the close relationship between self-efficacy and treatment outcomes, providers may want to target patients with low self- efficacy for interventions that focus on skills-training techniques.

Personal and treatment-related predictors of abstinence self-efficacy. Publishing Authors By Initials

M Ilgen,J McKellar,R Moos,

For similar human activities: temperance research abstracts see: human activities: temperance research

PUBMED ID PMID:

MEDLINE DATE:

Personal and treatment-related predictors of abstinence self-efficacy. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Journal of studies on alcohol and drugs

VOLUME: 68

Page Numbers: 126-32

Journal Abbreviation:

ISSN: 0096-882X

DAY: 3

MONTH: Jan

YEAR: 2007

Personal and treatment-related predictors of abstinence self-efficacy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101295847

Personal and treatment-related predictors of abstinence self-efficacy. Keywords Mesh Terms:

KEYWORDS: Temperance

MESH TERMS: psychology

Chemical & Substance for Abstract: Personal and treatment-related predictors of abstinence self-efficacy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Personal and treatment-related predictors of abstinence self-efficacy.

AFFILIATION: Center for Health Care Evaluation, Department of Veterans Affairs Palo Alto Health Care System and Stanford University School of Medicine, 795 Willow Road (MPD 152), Menlo Park, California 94025, USA. Mark.Ilgen@med.va.gov

Country: United States

AGENCY: United States NIAAA

GRANT: AA15685

ACRONYM: AA

MEDLINETA: J Stud Alcohol Drugs

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Personal and treatment-related predictors of abstinence self-efficacy Related Publications

• Active ingredients of substance use-focused self-help groups.
• Central anticholinergic syndrome: a case report.
• Conversation with Rudolf moos.
• Determinants of functioning and well-being among individuals with schizophrenia: an integrated model.
• Direct detection of formaldehyde in air by a novel NAD+- and glutathione-independent formaldehyde dehydrogenase-based biosensor.
• Effect of slow cathode rays on microorganisms.
• Emergent synchronous bursting of oxytocin neuronal network.
• Functioning status of adult children of depressed parents: a 23-year follow-up.
• Imaging performance of telescope mirrors for far-ultraviolet astronomy.
• Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis.
• Oxidative stress and damage in liver, but not in brain, of Fischer 344 rats subjected to dietary iron supplementation with lipid-soluble [(3,5,5-trimethylhexanoyl)ferrocene].
• Participation in specific treatment components predicts alcohol-specific and general coping skills.
• Personal and treatment-related predictors of abstinence self-efficacy.
• Predictors of 4-year outcome of community residential treatment for patients with substance use disorders.
• Predictors of changes in alcohol-related self-efficacy over 16 years.
• Predictors of outcome for patients with substance-use disorders five years after treatment dropout.
• Problem-free drinking over 16 years among individuals with alcohol use disorders.
• Protective resources and long-term recovery from alcohol use disorders.
• Screening psychiatric patients for illicit drug use disorders and problems.
• Solubilized human zona pellucida competes with a fucosylated neoglycoprotein for binding sites on the human sperm surface.
• Spatial imaging in the soft x-ray region (20-304 A) utilizing the astigmatism of a grazing incidence concave grating.
• Spirituality/religiosity promotes acceptance-based responding and 12-step involvement.
• Substance misuse among older adults: a neglected but treatable problem.
• Substance use disorder treatment programs in Switzerland and the USA: Program characteristics and 1-year outcomes.
• The basic aspects of radiation therapy.
• Treated and untreated alcohol-use disorders: course and predictors of remission and relapse.
• Upward pressures on drinking: exposure and reactivity in adulthood.
• Vg1 has specific processing requirements that restrict its action to body axis patterning centers.
• [Commentary] CONTEXT AND MECHANISMS OF REACTIVITY TO ASSESSMENT AND TREATMENT.
• [Not Available.]